[Changes induced by intravenous administration of potassium salts in the electrocardiogram and in urinary excretion and plasmatic and erythrocytic levels of sodium and potassium].
D000328:Adult; D000368:Aged; D001224:Aspartic Acid / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects*; D004562:Electrocardiography; D004573:Electrolytes / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000627:therapeutic use*; D011191:Potassium Deficiency / Q000188:drug therapy*
D002712:Chlorides; D004573:Electrolytes; D001224:Aspartic Acid; D005947:Glucose; D011188:Potassium
Modificazioni indotte dal carico endovenoso con sali di potassio sull'elettrocardiogramma, sull'escrezione urinaria e sulla concentrazione plasmatica ed eritrocitaria del sodio e del potassio.